This brand name is authorized in Brazil, Tunisia
The drug GELAFUNDIN contains one active pharmaceutical ingredient (API):
|
1
Succinyl gelatin
UNII 2G86QN327L - GELATIN, UNSPECIFIED
|
|
Gelatin is a colloidal plasma substitute. When used in the treatment of hypovolaemia gelatin produces significant increases in blood volume, cardiac output, stroke volume, blood pressure, urinary output and oxygen delivery. Gelatin promotes osmotic diuresis, thereby helping to protect the kidneys from the adverse effects of hypovolaemia. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B05AA06 | Gelatin agents | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 520901901152318 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7353022H |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
